Finding simple solutions for developing countries
using advanced technology
PARTNERS
|
| CONRAD |
|
| International Partnership for Microbicides |
|
| Esperanza Medicines Foundation |
|
| Loterie Romande |
|
| Avec le soutien de la République et Canton de Genève |
In February 2010 the Mintaka Foundation for Medical Research in Geneva announced that the Wellcome Trust, London, awarded it approximately CHF 4.5 Million ($4.25 Million) to meet the remaining costs of bringing its flagship product, an anti-HIV microbicide known as 5P12-RANTES, to a first safety trial in the clinic.
Welcome
|
|
